Kremen is beyond a subsidiary co-receptor of Wnt signaling: an in silico validation

Kremen-1 is a co-receptor of Wnt signaling, interacting with the Dkk-3 protein, which is an antagonist of the Wnt/ß catenin pathway. In the present study we attempted to shed some light on the possible orientations of Kremen/Dkk-3 interactions, explaining the mechanisms of Kremen and Dkk-3 functions. Employing state-of-the-art software, a Kremen model was built and subsequently refined. The quality of the final model was evaluated using RMSD calculations. Ultimately, we used the Kremen model for docking analysis between Kremen and Dkk-3 molecules. A model built by the Robetta server showed the best quality scores. Near native coordination of the final model was verified getting < 2 Å RMSD values between our model and an experimentally resolved structure. Docking analysis indicates that one low energy orientation for Kremen/Dkk-3 involves all extracellular domains of Kremen, while another only involves the CUB and WSC domains. Kremen receptors may determine either antitumor or protumor effects of the Dkk protein. Based on existing reports and our findings, we hypothesized that there could be different cellular fate outcomes due to the orientation of Kremen and Dkk-3 interactions. One orientation of the Kremen/Dkk complex could lead to Kringle mediated antitumor effects, while another could end with CUB mediated protumor effects.

Kremen is beyond a subsidiary co-receptor of Wnt signaling: an in silico validation

Kremen-1 is a co-receptor of Wnt signaling, interacting with the Dkk-3 protein, which is an antagonist of the Wnt/ß catenin pathway. In the present study we attempted to shed some light on the possible orientations of Kremen/Dkk-3 interactions, explaining the mechanisms of Kremen and Dkk-3 functions. Employing state-of-the-art software, a Kremen model was built and subsequently refined. The quality of the final model was evaluated using RMSD calculations. Ultimately, we used the Kremen model for docking analysis between Kremen and Dkk-3 molecules. A model built by the Robetta server showed the best quality scores. Near native coordination of the final model was verified getting < 2 Å RMSD values between our model and an experimentally resolved structure. Docking analysis indicates that one low energy orientation for Kremen/Dkk-3 involves all extracellular domains of Kremen, while another only involves the CUB and WSC domains. Kremen receptors may determine either antitumor or protumor effects of the Dkk protein. Based on existing reports and our findings, we hypothesized that there could be different cellular fate outcomes due to the orientation of Kremen and Dkk-3 interactions. One orientation of the Kremen/Dkk complex could lead to Kringle mediated antitumor effects, while another could end with CUB mediated protumor effects.

___

  • Ahn J-H, Kim J-S, Yu H-K, Lee H-J, Yoon Y (2004). A truncated Kringle domain of human apolipoprotein (a) inhibits the acti- vation of extracellular signal-regulated kinase 1 and 2 through a tyrosine phosphatase-dependent pathway. J Biol Chem 279: 21808–21814.
  • Ali RMM, Gurusamy PD, Ramachandran S (2014). Computational regulatory model for detoxification of ammonia from urea cycle in liver. Turk J Biol 38: 679–683.
  • Boudin E, Fijalkowski I, Piters E, Van Hul W (2013). The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin Arthritis Rheum 43: 220–240.
  • Chothia C, Lesk AM (1986). The relation between the divergence of sequence and structure in proteins. The EMBO J 5: 823.
  • Clevers H (2006). Wnt/β-catenin signaling in development and dis- ease. cell 127: 469–480.
  • Kim BM, Lee DH, Choi HJ, Lee KH, Kang SJ, Joe Y, Hong YK, Hong SH (2012). The recombinant Kringle domain of urokinase plasminogen activator inhibits VEGF165‐induced angiogen- esis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction. IUBMB Life 64: 259–265.
  • Kim KS, Hong Y-K, Joe YA, Lee Y, Shin J-Y, Park H-E, Lee I-H, Lee S-Y, Kang D-K, Chang S-I (2003). Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells. J Biol Chem 278: 11449–11456.
  • Kopp J, Schwede T (2004). Automated protein structure homology modeling: a progress report. Pharmacogenomics 5: 405–416.
  • Liangbing C, Qingzhi L, Lili L (2014). The modeled structures of Deg5 and Deg8 proteases in Arabidopsis thaliana. Turk J Biol 38: 168–176.
  • Liu H, Ong S-E, Badu-Nkansah K, Schindler J, White FM, Hynes RO (2011). CUB-domain–containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci 108: 1379–1384.
  • Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Na- ture 417: 664–667.
  • Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf pro- teins. Nature 411: 321–325.
  • Moult J (2005). A decade of CASP: progress, bottlenecks, and prog- nosis in protein structure prediction. Curr Opin Struct Biol 15: 285–289.
  • Nakamura RE, Hackam AS (2010). Analysis of Dickkopf3 interac- tions with Wnt signaling receptors. Growth Factors 28: 232– 242.
  • Nakamura T, Aoki S, Kitajima K, Takahashi T, Matsumoto K, Na- kamura T (2001). Molecular cloning and characterization of Kremen, a novel Kringle-containing transmembrane protein. Biochim. Biophys Acta Gene Struct Expression 1518: 63–72.
  • Nakamura T, Matsumoto K (2008). The functions and possible sig- nificance of Kremen as the gatekeeper of Wnt signalling in de- velopment and pathology. J Cell Mol Med 12: 391–408.
  • Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sug- imura A, Tashiro K, Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443.
  • Nguyen M, Tan K, Madhusudhan M (2011). CLICK—topology-in- dependent comparison of biomolecular 3D structures. Nucleic Acids Res 39: W24–W28.
  • Oishi I, Sugiyama S, Liu Z-J, Yamamura H, Nishida Y, Minami Y (1997). A novel drosophila receptor tyrosine kinase expressed specifically in the nervous system unique structural features and implication in developmental signaling. J Biol Chem 272: 11916–11923.
  • Perry SE, Robinson P, Melcher A, Quirke P, Bühring H-J, Cook GP, Blair GE (2007). Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells. FEBS Lett 581: 1137–1142.
  • Persson B, Argos P (1996). Topology prediction of membrane pro- teins. Protein Sci 5: 363–371.
  • Poorinmohammad N, Mohabatkar H (2014). Identification of HLA- A* 0201-restricted CTL epitopes from the receptor-binding domain of MERS-CoV spike protein using a combinatorial in silico approach. Turk J Biol 38: 628–632.
  • Rawlings CJ, Taylor WR, Nyakairu J, Fox J, Sternberg MJE (1985). Reasoning about protein topology using the logic program- ming language PROLOG. J Mol Graphics 3: 151–157.
  • Reva BA, Finkelstein AV, Skolnick J (1998). What is the probability of a chance prediction of a protein structure with an rmsd of 6 Å? Folding Des 3: 141–147.
  • Uekita T, Fujii S, Miyazawa Y, Hashiguchi A, Abe H, Sakamoto M, Sakai R (2013). Suppression of autophagy by CUB domain‐ containing protein 1 signaling is essential for anchorage‐inde- pendent survival of lung cancer cells. Cancer Sci 104: 865–870.
  • Uekita T, Sakai R (2011). Roles of CUB domain‐containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci 102 :1943–1948.
  • Zhang Y, Mao B (2010). Embryonic expression and evolutionary analysis of the amphioxus Dickkopf and Kremen family genes. J Genet Genomics 37: 637–645.
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Diazoxide attenuates ROS generation and exerts cytoprotection under conditions of ROS overproduction in rat uterus cells

Olga VADZYUK, Sergiy KOSTERIN

A letter in response to "Cancer stem cells: emerging actors in both basic and clinical cancer research" Turk J Biol (2014) 38: ©TÜBITAK - doi:10.3906/biy-1406-93 Cancer stem cells (CSCs): targets and strategies for intervention

SURESH PALAMADAI KRISHNAN

Changes in gene expression in SIRT3 knockout liver cells

Randa TAO, Jamie LECLERC, Kübra YILDIZ, Seong-hoon PARK, Barbara JUNG, David GIUS, Özkan ÖZDEN

Evaluation of the phytoremediation capacity of Lemna minor L. in crude oil spiked cultures

Taylan KÖSESAKAL, Vesile Selma ÜNLÜ, Oktay KÜLEN, Abdülrezzak MEMON, Bayram YÜKSEL

Investigation of the in vivo interaction between ß-lactamase and its inhibitor protein

Nilay Büdeyri GÖKGÖZ, Simay YALAZ, Naze Gül AVCI, Gizem BULDUM, Elif Özkirimli ÖLMEZ, Berna Sariyar AKBULUT

In vitro high frequency regeneration through apical shoot proliferation of Hemianthus callitrichoides `Cuba' - a multipurpose ornamental aquatic plant

Surendra BARPETE, Sancar Fatih ÖZCAN, Muhammad AASIM, Sebahattin ÖZCAN

Ultrastructural effects of lead acetate on the spleen of rats

MESURE TÜRKAY, HÜSEYİN TÜRKER, TURAN GÜVEN

Whole-genome DNA methylation analysis in cotton (Gossypium hirsutum L.) under different salt stresses

Xuke LU, Xiaojie ZHAO, Delong WANG, Zujun YIN, Junjuan WANG, Weili FAN, Shuai WANG, Tianbao ZHANG, Wuwei YE

A letter in response to "Cancer stem cells: emerging actors in both basic and clinical cancer research" Turk J Biol (2014) 38: ©TÜBITAK - doi:10.3906/biy-1406-93 Cancer stem cells (CSCs): targets and strategies for intervention

SURESH PALAMADAI KRISHNAN

Histone deacetylase inhibitory activity of hydroxycapsaicin, a synthetic derivative of capsaicin, and its cytotoxic effects against human colon cancer cell lines

Thanaset SENAWONG, Paweena WONGPHAKHAM, Thussanee SAIWICHAI, Chanokbhorn PHAOSIRI, Pakit KUMBOONMA